Acetylsalicylic acid Completed Phase 4 Trials for Type 2 Diabetes Mellitus Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT00812032Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients